Nohla Therapeutics has signed an exclusive supply agreement with LifeSouth Community Blood Centers headquartered in Gainesville, Florida. Under this agreement, LifeSouth’s cord blood banking program will supply Nohla Therapeutics with clinical grade cord blood units that will be used in the production process for the Company’s expanded hematopoietic stem and progenitor cell (HSC/HPC) products. [Read more…]
PRESS RELEASE; Washington, DC; November 17, 1015 — BioInformant, the only market research firm to serve the stem cell sector since it emerged, announces its sponsorship of the upcoming World Stem Cell Summit 2015 produced by the Genetics Policy Institute (GPI). The conference will be held in Atlanta, Georgia, over December 10-12, 2015.
The event is the world’s largest interdisciplinary meeting to bring together stakeholders from across the stem cell and regenerative medicine spectrum. Described as GPI as bringing together “prominent industry leaders, scientists, clinicians, venture capitalists and angel investors, philanthropists, policymakers, and advocates,” the event will provide seven different course tracks featuring more than 200 speakers. [Read more…]
AUTHOR: Authored by Wendy Roberts, PR Director of Orca Communications Unlimited, LLC.
COMMENT BY BIOINFORMANT: Leading global players within cord blood industry frequently attain their industry dominance through industry collaborations. In the announcement below, released May 11, 2015, CariCord and ClinImmune Labs announce a major industry partnership that will study the survivability of umbilical cord blood stem cells under micro gravity (Micro-G) simulation.
CariCord, a private stem cell bank at the University of Colorado, is a FDA-licensed cord blood manufacturer that has processed nearly 9,000 cord blood units and released 700+ for transplantation across 150+ hospitals worldwide. While CariCord is not as substantial in size as other key players within the U.S. cord blood industry (most notably Cord Blood Registry, ViaCord, and Cryo-Cell, respectively) the company is positioning itself for increased visibility and growth through this strategic collaboration. [Read more…]
PRESS RELEASE; April 1, 2015
WASHINGTON, DC, and TUCSON, AZ
Press release available at PR Web: http://www.prweb.com/
For expectant parents, there are thousands of decisions to make in a short amount of time, including clothes, cribs, names, birthing methods, medical procedures, and more. It can be overwhelming, especially given the short-time frame involved. In addition to these decisions, there is an often overlooked decision: what to do with the extremely valuable stem and progenitor cells contained within the umbilical cord of the expected newborn? There are three options, which are to publicly donate, to privately store, or to discard the umbilical cord as medical waste. Two of those decisions require research and action on behalf of the parents, while the third is what happens when sufficient awareness and education has not been provided to allow parents to make an informed, educated decision. [Read more…]